Why is Germany's CureVac vaccine just 48% effective? | Covid-19 Special
Автор: DW News
Загружено: 2021-08-05
Просмотров: 40907
Описание:
CureVac's COVID-19 jab did not turn out what many hoped it would be. That's despite using the same messenger RNA technology as rivals Moderna and BioNTech-Pfizer. CureVac aimed to produce its vaccine primarily for developing countries – as it can be stored more easily than other products. And despite disappointing trial-results the company is sticking to the plan.
Subscribe: https://www.youtube.com/user/deutsche...
For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: / deutschewellenews
►Twitter: / dwnews
►Instagram: / dwnews
Für Videos in deutscher Sprache besuchen Sie: / dwdeutsch
#CureVac #Covid19 #coronavirus
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
